IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis

BACKGROUND: IL-17A has recently emerged as a potential target that regulates the extensive inflammation and abnormal bone formation observed in ankylosing spondylitis (AS). Blocking IL-17A is expected to inhibit bony ankylosis. Here, we investigated the effects of anti IL-17A agents in AS. METHODS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Jo, Sungsin, Wang, Sung Eun, Lee, Young Lim, Kang, Suman, Lee, Bitnara, Han, Jinil, Sung, Il-Hoon, Park, Ye-Soo, Bae, Sang-Cheol, Kim, Tae-Hwan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992730/
https://ncbi.nlm.nih.gov/pubmed/29880011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1582-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars